End-of-day quote
Colombo S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
6.9
LKR
|
+1.47%
|
|
-1.43%
|
+6.15%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,785
|
3,785
|
2,753
|
3,909
|
6,059
|
10,847
|
Enterprise Value (EV)
1 |
6,703
|
7,435
|
8,672
|
12,872
|
20,856
|
31,793
|
P/E ratio
|
3.59
x
|
2.4
x
|
7.29
x
|
-34.3
x
|
61.2
x
|
-3.15
x
|
Yield
|
7.27%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.3
x
|
0.25
x
|
0.16
x
|
0.19
x
|
0.24
x
|
0.36
x
|
EV / Revenue
|
0.53
x
|
0.5
x
|
0.49
x
|
0.63
x
|
0.81
x
|
1.06
x
|
EV / EBITDA
|
1.65
x
|
1.84
x
|
1.89
x
|
3.9
x
|
7.68
x
|
6.38
x
|
EV / FCF
|
1.34
x
|
5.95
x
|
-2.19
x
|
-4.11
x
|
-4.63
x
|
12.5
x
|
FCF Yield
|
74.9%
|
16.8%
|
-45.7%
|
-24.3%
|
-21.6%
|
7.97%
|
Price to Book
|
0.86
x
|
0.72
x
|
0.51
x
|
0.62
x
|
0.99
x
|
4.56
x
|
Nbr of stocks (in thousands)
|
688,160
|
688,160
|
688,160
|
977,187
|
977,187
|
977,187
|
Reference price
2 |
5.500
|
5.500
|
4.000
|
4.000
|
6.200
|
11.10
|
Announcement Date
|
8/31/18
|
8/7/19
|
8/31/20
|
7/28/21
|
8/31/22
|
8/31/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
12,760
|
14,890
|
17,732
|
20,430
|
25,640
|
29,902
|
EBITDA
1 |
4,057
|
4,040
|
4,589
|
3,302
|
2,717
|
4,985
|
EBIT
1 |
3,737
|
3,722
|
4,246
|
2,948
|
2,372
|
4,656
|
Operating Margin
|
29.29%
|
25%
|
23.95%
|
14.43%
|
9.25%
|
15.57%
|
Earnings before Tax (EBT)
1 |
1,788
|
1,033
|
1,370
|
886.8
|
1,767
|
-626
|
Net income
1 |
1,050
|
1,579
|
377.4
|
-95.23
|
99
|
-3,443
|
Net margin
|
8.23%
|
10.61%
|
2.13%
|
-0.47%
|
0.39%
|
-11.51%
|
EPS
2 |
1.530
|
2.295
|
0.5484
|
-0.1166
|
0.1013
|
-3.524
|
Free Cash Flow
1 |
5,019
|
1,250
|
-3,961
|
-3,132
|
-4,508
|
2,535
|
FCF margin
|
39.33%
|
8.39%
|
-22.34%
|
-15.33%
|
-17.58%
|
8.48%
|
FCF Conversion (EBITDA)
|
123.72%
|
30.93%
|
-
|
-
|
-
|
50.86%
|
FCF Conversion (Net income)
|
477.8%
|
79.12%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.4000
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/31/18
|
8/7/19
|
8/31/20
|
7/28/21
|
8/31/22
|
8/31/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,918
|
3,650
|
5,919
|
8,963
|
14,798
|
20,946
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.7193
x
|
0.9034
x
|
1.29
x
|
2.714
x
|
5.446
x
|
4.202
x
|
Free Cash Flow
1 |
5,019
|
1,250
|
-3,961
|
-3,132
|
-4,508
|
2,535
|
ROE (net income / shareholders' equity)
|
34.5%
|
36.4%
|
11.8%
|
3.31%
|
9.05%
|
-25.5%
|
ROA (Net income/ Total Assets)
|
6.42%
|
5.81%
|
5.76%
|
3.4%
|
2.3%
|
4.03%
|
Assets
1 |
16,352
|
27,171
|
6,546
|
-2,803
|
4,305
|
-85,518
|
Book Value Per Share
2 |
6.380
|
7.650
|
7.900
|
6.470
|
6.280
|
2.440
|
Cash Flow per Share
2 |
2.140
|
2.230
|
1.000
|
1.380
|
1.230
|
1.570
|
Capex
1 |
235
|
200
|
353
|
104
|
108
|
165
|
Capex / Sales
|
1.84%
|
1.34%
|
1.99%
|
0.51%
|
0.42%
|
0.55%
|
Announcement Date
|
8/31/18
|
8/7/19
|
8/31/20
|
7/28/21
|
8/31/22
|
8/31/23
|
|
1st Jan change
|
Capi.
|
---|
| +6.15% | 22.79M | | +14.78% | 79.51B | | +6.49% | 50.22B | | +1.35% | 48.11B | | +6.55% | 39.71B | | +19.34% | 37.78B | | +2.84% | 30.07B | | -7.77% | 27.56B | | -18.42% | 24.71B | | +6.89% | 21.99B |
Other Life & Health Insurance
|